Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre décroissant Titre Date Coup de coeur Thématique
Clinical Gastroenterology and Hepatology Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. mar. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis. sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. juil. 17 2 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. mai. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates. sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study juil. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes. oct. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Cesarean Section Delivery Is Not a Risk Factor for Development of Inflammatory Bowel Disease: A Population-based Analysis. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies Jan. 19 4 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression juin. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. juin. 16 2 ♥ MICI
Clinical Gastroenterology and Hepatology Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease sep. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis juil. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis aoû. 17 4 ♥ MICI
Clinical Gastroenterology and Hepatology Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed oct. 17 2 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Disease mai. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010 juin. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. juin. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. oct. 16 3 ♥ MICI

Pages